In vivo and in silico evaluations of a synthetic pyrano[3,2-c]quinoline derivative as a potent anti-diabetic agent

ConclusionIn summary, the study demonstrated thein vivo anti-hyperglycemic activity of2-BDBPQD. Nevertheless, furtherin vivo evaluations are recommended to comprehensively assess its potential as a new drug for the treatment of diabetes.
Source: Journal of Diabetes and Metabolic Disorders - Category: Endocrinology Source Type: research